← Back to Search

Heidelberg Spectralis OCT for Glaucoma

N/A
Waitlist Available
Led By Balwantray Chauhan, OD
Research Sponsored by Heidelberg Engineering GmbH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy eye without prior intraocular surgery (except cataract surgery and Laser in Situ Keratomileusis) and without clinically significant vitreal, retinal or choroidal diseases, clinically significant diabetic retinopathy (subject may have diabetes), or disease of the optic nerve. Small drusen are acceptable in older subjects.
Negative history of glaucoma (not including family history)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will study the normal structural parameters of the optic nerve, the retina, and the macula in Hispanic volunteers. The goal is to provide the range of these parameters in normal eyes. The study will include at least 240 volunteers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bruch-Membrane-Opening - Minimum Rim Area (µm^2)
Bruch-Membrane-Opening - Minimum Rim Width (µm)
Peripapillary Retinal Nerve Fibre Layer Thickness (µm)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Normal healthy volunteersExperimental Treatment1 Intervention
imaging with Heidelberg Spectralis OCT

Find a Location

Who is running the clinical trial?

Heidelberg Engineering GmbHLead Sponsor
15 Previous Clinical Trials
1,780 Total Patients Enrolled
5 Trials studying Glaucoma
625 Patients Enrolled for Glaucoma
Balwantray Chauhan, ODPrincipal InvestigatorDepartment of Ophthalmology and Visual Sciences Dalhousie University
1 Previous Clinical Trials
234 Total Patients Enrolled
1 Trials studying Glaucoma
234 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 18 or over eligible to participate in the experiment?

"According to the eligibility criteria, participants must be aged between 18 and 90. Meanwhile, there are 23 trials specifically designed for individuals below age 18 and 191 clinical investigations targeting those above 65 years old."

Answered by AI

How extensive is the participant pool for this research endeavor?

"Affirmative, the clinicaltrials.gov website reveals that this research is presently enrolling individuals. This particular investigation was originally made public on June 1st 2016 and recently edited May 4th 2022. In total, 249 participants need to be enrolled from one single centre."

Answered by AI

Could I potentially enroll in this trial?

"This experiment is open to individuals in the age range of 18-90 who have glaucoma. A total of 249 volunteers are needed for this clinical trial."

Answered by AI

Is it possible to enroll in this clinical trial at present?

"According to clinicaltrials.gov, this trial is presently seeking individuals for participation. It was originally posted on June 1st 2016 and most recently modified on May 4th 2022."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~26 spots leftby Mar 2025